Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: A systematic review

Respirology

Volumn 15, Issue 3, 2010, Pages 536-542

  Mohan, Anant ^a   Chandra, Subhash ^b   Agarwal, Dipti ^b   Guleria, Randeep ^a   Broor, Shobha ^a   Gaur, Bharti ^a   Pandey, Ravindra Mohan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b MAYO CLINIC   (United States)

Author keywords

Chronic obstructive pulmonary disease; Polymerase chain reaction; Respiratory virus

Indexed keywords

ADENOVIRUS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONAVIRUS; DISEASE EXACERBATION; HUMAN; INFLUENZA VIRUS; MIXED INFECTION; PARAINFLUENZA VIRUS; PICORNAVIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; VIRAL RESPIRATORY TRACT INFECTION;

COMORBIDITY; HUMANS; POLYMERASE CHAIN REACTION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS DISEASES;

EID: 77950218212     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01722.x     Document Type: Article

References (25)

1. World Health Organization. The 10 leading causes of death by broad income group, 2004. Fact sheet No 310/November 2008.
2. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int. J. Tuberc. Lung. Dis. 2008 12 : 703 708.
3. Connors AF Jr., Dawson NV, Thomas C et al. Outcomes following acute exacerbations of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 1996 154 : 959 967.
4. Seemungal TAR, Donaldson GC, Paul EA et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998 157 : 1418 1422.
5. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000 117 (Suppl. 2 5S 9S.
6. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000 117 (5 Suppl. 2 380S 5S.
7. Kuypers J, Campbell AP, Cent A et al. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl. Infect. Dis. 2009 11 : 298 303.
8. Von Elm E, Altman DG, Egger M et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 2008 61 : 344 349.
9. Beckham JD, Cadena A, Lin J et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J. Infect. 2005 50 : 322 330.
10. Camargo CA Jr., Ginde AA, Clark S et al. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern. Emerg. Med. 2008 3 : 355 359.
11. Ko FW, Ip M, Chan PK et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 2007 132 : 900 908.
12. Rohde G, Wiethege A, Borg I et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003 58 : 37 42.
13. Hutchinson AF, Ghimire AK, Thompson MA et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir. Med. 2007 101 : 2472 2481.
14. Papi A, Bellettato CM, Braccioni F et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006 173 : 1114 1121.
15. McManus TE, Marley AM, Baxter N et al. Respiratory viral infection in exacerbations of COPD. Respir. Med. 2008 102 : 1575 1580.
16. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001 164 : 1618 1623.
17. Anthonisen NR, Manfreda J, Warren CP et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987 106 : 196 204.
18. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007 176 : 532 555.
19. American Thoracic Society. ATS statement: standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995 152 : S78 S83.
20. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization and mortality in elderly persons with chronic lung disease. Ann. Intern. Med. 1999 130 : 397 403.
21. Poole PJ, Chacko E, Wood-Baker RW et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2006 1 CD002733.
22. Rohde G, Borg I, Arinir U et al. Relevance of human metapneumovirus in exacerbations of COPD. Respir. Res. 2005 6 : 150.
23. Wedzicha JA, Seemungal TA, MacCallum PK et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb. Haemost. 2000 84 : 210 215.
24. Nichol KL, Nordin J, Mullooly J et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 2003 348 : 1322 1332.
25. Van den Hoogen BG, de Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001 7 : 719 724.